Induction of p27kip1 by 2,4,3′,5′- tetramethoxystilbeneis regulated by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells

Archives of Pharmacal Research

Volumn 31, Issue 9, 2008, Pages 1187-1194

  Kim, Sang Woo ^a   Jung, Hong Keun ^a   Kim, Mie Young ^a  

^a Chung Ang University   (South Korea)

Author keywords

Akt; p27kip1; PC 3 cells; Protein phosphatase 2A; Skp2; Stilbene

Indexed keywords

2,4,3',5' TETRAMETHOXYSTILBENE; 2,4,3',5'-TETRAMETHOXYSTILBENE; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; ONCOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2; S PHASE KINASE ASSOCIATED PROTEIN; SMALL INTERFERING RNA; STILBENE DERIVATIVE;

ARTICLE; BIOSYNTHESIS; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; DRUG EFFECT; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; HUMAN; MALE; METABOLISM; MITOCHONDRIAL MEMBRANE; PATHOLOGY; PHOSPHORYLATION; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA, COMPLEMENTARY; FLOW CYTOMETRY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; MALE; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN PHOSPHATASE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; STILBENES; TRANSFECTION;

EID: 54549108054     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1287-1     Document Type: Article

References (37)

1. kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res., 6, 3264-3272 (2005).
2. Aziz, M. H., Kumar, R., and Ahmad, N., Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol., 23, 17-28 (2003).
3. Benitez, D. A., Pozo-Guisado, E., Alvartez-Barrientos, A., Fernandez-Salguero, P. M., and Castellon, E. A., Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J. Androl., 28, 282-293 (2007).
4. kip1 in prostate cancer. J Urol., 170, 241-245 (2003).
5. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E., Akt promotes cell survival by phosphorylating and inhibiting a Forkead transcription factor. Cell,96, 857-868 (1999).
6. Carrano, A. C., Eytan, R E., Hershko, A., and Pagano, M., Skp2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell. Biol., 1, 193-199 (1999).
7. kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res., 58, 542-548 (1998).
8. Chen, J.-H., Hurh, Y.-J., Na, H.-K., Kim, J.-H., Chun, Y.-J., Kim, D.-H., Kang, K.-S., Cho, M. H., and Surh, Y.-J., Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis, 25, 2005-2013 (2004).
9. Chun, Y.-J., Kim, S., Kim, D., Lee, S.-K., and Guengerich, F. P., A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res., 61, 8164-8170 (2001).
10. Chun, Y-J., Lee, S-K., and Kim, M. Y., Modulation of human cytochrome P450 1B1 expression by 2,4,3′,5′-tetramethoxystilbene. Drug Metab. Dispos., 33, 1771-1776 (2005).
11. Ciolino, H. P., Daschner, P. J., and Yeh, G. C., Resveratol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res.,58, 5707-5712 (1998).
12. kip1 regulation in LNCaP and PC346 cells. Prostate, 66, 749-760 (2006).
13. Ekholm, S. V. and Reed, S. I., Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin.Cell Biol., 12, 676-684 (2000).
14. Gill, C., Walsh, S. E., Morrissey, C., Fitzpatrick, J. M., and Watson, W. G., Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate, 67, 1641-1653 (2007).
15. kip1 expression. J. Biol. Chem., 275, 24500-24505 (2000).
16. Green, D. R. and Reed, J. C., Mitochondria and apoptosis. Science, 281, 1309-1312 (1998).
17. Guengerich, F. P., Chun, Y.-J., Kim, D., Gillam, E. M. J., and Shimada, T., Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat. Res., 523-4, 173-182 (2003).
18. Guo, Y., Sklar, G. N., Borkowski, A., and Kyprianou, N., Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Clin.Cancer Res., 12, 2269-2274 (1997).
19. Hsieh, T. C. and Wu, J. M., Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res., 249, 109-115 (1999).
20. Jang, M., Cai, L., and Udeani, G. O., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220 (1997).
21. Janssens, V., Goris, J., and Van Hoof, C., PP2A: the expected tumor suppressor. Curr. Opin. Genet. Dev., 15, 34-41 (2005).
22. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay, N., The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11, 701-713 (1997).
23. kip1 in ceramide-mediated apoptosis in HL-60 cells. Cancer Lett., 151, 39-48 (2000).
24. kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol., 154, 313-23 (1999).
25. Millward, T. A., Zoinierowicz, S., and Hemmings, B. A., Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci., 24, 186-191 (1999).
26. Montagnoli, A., Fiore, F., Eytan, E., Carrano, A. C., Draetta, G. F., Hershko, A., and Pagano, M., Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev., 13, 1181-1189 (1999).
27. kip1 expression and localization. Am. J. Pathol., 166, 737-749 (2005).
28. Pervaiz, S., Resveratrol: from grapevines to mammalian biology. FASEB J., 17, 1975-1985 (2003).
29. Reichert, M., Saur, D., Hamacher, R., Schmid, R. M., and Schneider, G., Phosphoinositide-3-kinase signaling controls S-Phase Kinase-Associated protein 2 transcription via E2F-1 in pancreatic ductal adenocarcinoma cells. Cancer Res.,67, 4149-4156 (2007).
30. Sgambato, A., Cittadini, A., Faraglia, B., and Weinstein, I. B., Multiple function of p27(kip1) and its alterations in tumor cells: A review. J. Cell Physiol., 183, 18-27 (2000).
31. kip1 at threonine 157 and modulation of its cellular localization. Nat. Med., 8, 1145-1152 (2000).
32. kip1 and its deregulation in cancer. J. Cell Physiol.,183, 10-17 (2000).
33. Subbaramaiah, K., Chung W. J., Michaluart, P., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., and Dannenberg, A. J., Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273, 21875-21882 (1998).
34. Testa, J. R. and Bellacosa, A., Akt plays a central role in tumorigenesis. Proc. Natl. Acad. Sci. USA., 98, 10983-10985 (2001).
35. Tsihlias, J., Kapusta, L. R., DeBoer, G., Morava-Protzner, I., Zbieranowski, I., Bhattacharya, N., Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., G. Del Sal, Chau, B., Yew, P. R., Draetta, G. F., and Rolfe, M., Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science, 269, 682-685 (1995).
36. kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nature Med., 8, 1136-1144 (2002).
37. Yin, K. J., Hsu, C. Y., Hu, X. Y., Chen, H., Chen, S. W., Xu, J., and Lee, J. M., Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-beta peptide-induced cerebrovascular endothelial cell death. J Neurosci., 26, 2290-2299 (2006).